Latest News by Industry
MADISON, Wis. (AP) _ Exact Sciences Corp. (EXAS) on Thursday reported a loss of $148.8 million in its third quarter.
On a per-share basis, the Madison, Wisconsin-based company said it had a loss of 84 cents.
The results surpassed Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of $1.10 per share.
The molecular diagnostics company posted revenue of $523.1 million in the period, which also topped Street forecasts. Seven analysts surveyed by Zacks expected $500.8 million.
Exact Sciences expects full-year revenue in the range of $2.03 billion to $2.04 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a EXAS">Zacks stock report on EXAS at https://www.zacks.com/ap/EXAS